Announce Date | 04/28/2025 |
EPS Normalized Actual | $0.56 (Beat by $0.13) |
EPS GAAP Actual | $0.56 (Beat by $0.13) |
Revenue Actual | $0.019737B |
Revenue Surprise | Beat by $19.737M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.452 |
EPS GAAP Estimate | $0.452 |
Revenue Estimate | $0.0528606B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 2.55 | 8.34 | 2.38494 | 2.73201 | 1 |
Dec 2025 | 1.525 | 13.95 | 1.35 | 1.65 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.56 | 0.172 | 0.019737B | -276.76% | -31.11M |
FQ4 2024 (Dec 2024) | 0 | -0.402 | 0.067646B | 32.76% | 17.22M |
FQ3 2024 (Sep 2024) | 0.26 | -1.28141 | 0.080575B | 100% | -15.65M |
FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 0.080393B | 100% | 80.39M |
FQ1 2024 (Mar 2024) | 0.33 | 0.33 | 0.074361B | 100% | 74.36M |
FQ4 2023 (Dec 2023) | -0.75 | -0.75 | 0.045486B | 100% | 45.49M |
FQ3 2012 (Sep 2012) | 0.35 | 0.35 | 0.03163B | 100% | 31.63M |
FQ4 2012 (Dec 2012) | 0.32 | 0.32 | 0.039093B | 100% | 39.09M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.452
Consensus Revenue Estimates
0.0528606B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.66 | -- | 0.65462 | 0.66624 | 0 |
FQ3 2026 (Jul 2026) | 0.62 | -- | 0.61494 | 0.62587 | 0 |
FQ2 2026 (Jun 2026) | 0.64 | -- | 0.63325 | 0.64889 | 0 |
FQ1 2026 (Mar 2026) | 0.61 | 8.2 | 0.60356 | 0.61848 | 0 |
FQ4 2025 (Oct 2025) | 0.458 | -- | 0.44522 | 0.47533 | 1 |
FQ3 2025 (Jul 2025) | 0.422 | 38.39 | 0.41022 | 0.43796 | 1 |
FQ2 2025 (Jun 2025) | 0.452 | 31.42 | 0.44232 | 0.46489 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
FQ3 2026 (Jul 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
FQ2 2026 (Jun 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
FQ1 2026 (Mar 2026) | 0.07B | 71.58 | 0.07B | 0.07B | 1 |
FQ4 2025 (Oct 2025) | 0.05B | -25.9 | 0.05B | 0.06B | 0 |
FQ3 2025 (Jul 2025) | 0.05B | -54.1 | 0.05B | 0.05B | 0 |
FQ2 2025 (Jun 2025) | 0.05B | -52.08 | 0.05B | 0.05B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.388 | 0.56 | 0.172 | 30.71% |
FQ4 2024 (Dec 2024) | 0.402 | 0 | -0.402 | -INF% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.26 | -1.28141 | -492.85% |
FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 100% | |
FQ1 2024 (Mar 2024) | 0.33 | 0.33 | 100% | |
FQ4 2023 (Dec 2023) | -0.75 | -0.75 | 100% | |
FQ3 2012 (Sep 2012) | 0.35 | 0.35 | 100% | |
FQ4 2012 (Dec 2012) | 0.32 | 0.32 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.05B | $0.02B | $-31.11M | -157.64% |
FQ4 2024 (Dec 2024) | $0.05B | $0.07B | $17.22M | 25.45% |
FQ3 2024 (Sep 2024) | $0.1B | $0.08B | $-15.65M | -19.42% |
FQ2 2024 (Jun 2024) | $0B | $0.08B | $80.39M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.07B | $74.36M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.05B | $45.49M | 100% |
FQ3 2012 (Sep 2012) | $0B | $0.03B | $31.63M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.04B | $39.09M | 100% |